2 Results for "

STAT3/HDAC-IN-2

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "STAT3/HDAC-IN-2" in MCE Product Catalog:

  • Targets Recommended:
Cat. No.: HY-162828
Target:  

STAT HDAC

Research Areas:  

Cancer

STAT3/HDAC-IN-2 (compound 18) is a dual inhibitor of STAT3 and HDAC, inducing autophagy and apoptosis. STAT3/HDAC-IN-2 is an amphiphilic hydroxamic acid hybrid based on the natural product isopropanol lactone (IAL) and is a nanoscale anticancer agent. STAT3/HDAC-IN-2 can self-assemble in water to form nanoparticles, which have higher tumor tissue accumulation, cellular uptake and anticancer properties compared to the free state .
loading...
    loading...
Cat. No.: HY-149283
CAS No.: 3029138-43-7
Target:  

JAK HDAC Apoptosis

Research Areas:  

Cancer

JAK/HDAC-IN-2 is a potent 2-amino-4-phenylaminopyrimidine JAK/HDAC dual-target inhibitor. JAK/HDAC-IN-2 potently inhibits HDAC3/6 and JAK1/2 at nanomolar levels. JAK/HDAC-IN-2 has proapoptotic activity and inhibits histone deacetylation and STAT3 phosphorylation. JAK/HDAC-IN-2 presents remarkable antiproliferative activity in both hematological malignancies and solid cancers .
loading...
    loading...